COMMUNIQUÉS West-GlobeNewswire

HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China

30/08/2024 - 06:30

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has voluntarily withdrawn its supplemental New [...]

Raw Garden Announces End of Summer and Labor Day Deals

30/08/2024 - 02:50

Premier cannabis cultivator offers up to 40% off at participating retailers across California SANTA BARBARA, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Raw Garden , California's premier cannabis cultivator, manufacturer [...]

Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference

30/08/2024 - 01:32

AI-generated, compact SMART nucleases demonstrated robust genome editing activity in vitro in mammalian cells at multiple therapeutically relevant loci Compact SMART genome editing tools that fit within delivery [...]

ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split

29/08/2024 - 22:50

The combined company will operate as “Oruka Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “ORKA” effective Tuesday, September 3, 2024 WESTMINSTER, Colo., Aug. 29, 2024 (GLOBE NEWSWIRE [...]

Ultragenyx to Participate in Investor Conferences in September

29/08/2024 - 22:30

Morgan Stanley 22 nd Annual Global Healthcare Conference on September 4 Cantor Global Healthcare Conference on September 17 Bank of America Global Healthcare Conference on September 18 NOVATO, Calif., Aug. 29, 2024 ( [...]

Umoja Biopharma to Participate in Upcoming Investor Conferences in September

29/08/2024 - 22:30

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies [...]

StateHouse Reports Second Quarter 2024 Financial Results

29/08/2024 - 22:30

Q2 2024 Net Revenue Increase d 10% to $27.8 Million and Gross Margin Remains Strong at 50.8 % Achieved Positive Net Income of $0.2 Million and Adjusted EBITDA of $4.9 Million in Q2 2024 SAN DIEGO and TORONTO, Aug. 29, [...]

WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters’ Over-Allotment Option

29/08/2024 - 22:30

Hangzhou, China, Aug. 29, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (the “Company”), a supplier of medical devices in China, today announced the underwriter of its initial public offering [...]

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

29/08/2024 - 22:25

Vancouver, Canada, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

29/08/2024 - 22:25

TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders [...]

Kane Biotech Announces Second Quarter 2024 Financial Results

29/08/2024 - 22:15

Company Realizes $10.4M Gain on the Sale of STEM WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its second [...]

Sana Biotechnology to Present at September 2024 Investor Conferences

29/08/2024 - 22:05

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

29/08/2024 - 22:05

Strong balance sheet with successful completion of upsized $179.0 million initial public offering Treatment initiated in the first patient in an investigator-initiated basket trial of AlloNK® exploring multiple [...]

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

29/08/2024 - 22:05

IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

29/08/2024 - 22:05

SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29/08/2024 - 22:01

LEXINGTON, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with a newly [...]

Cytokinetics to Participate in September Investor Conferences

29/08/2024 - 22:00

SOUTH SAN FRANCISCO, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in the following investor conferences in September: [...]

Radiance BioPharma sponsoring Investor Cruise Event 2024

29/08/2024 - 21:30

BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Radiance Biopharma Inc., a biopharmaceutical company developing next generation Antibody Drug Conjugates and Bispecific Antibody Drug Conjugates announced that Robert K. Brooks [...]

EssilorLuxottica: successful Euro 2 billion bond issuance at 2.99%

29/08/2024 - 19:46

NOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR [...]